Galiximab
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Galiximab, covering 2011-01-07 to 2016-07-06. Get the full timeline:
Most recent: Clinical Trial Update: Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma [Phase 2]